Literature DB >> 18926300

GM-CSF in the generation of dendritic cells from human blood monocyte precursors: recent advances.

Lucia Conti1, Sandra Gessani.   

Abstract

Dendritic cells (DCs) play a key role in the orchestration of the immune system by virtue of their capacity to control both immunity and tolerance induction. The functions of DCs depend on the subset as well as their location and activation state. A number of in vitro protocols, developed to recapitulate DC generation from hematopoietic precursors, have suggested the importance of microenvironment and cytokine milieu in driving the generation of DCs endowed with peculiar phenotypic and functional features. Recently, some important concepts on the development of DCs from human blood monocytes have been challenged. The finding that human DCs can be generated from monocytes in the presence of granulocyte/macrophage colony-stimulating factor (GM-CSF) alone points to this cytokine as a direct player, rather than a survival-promoting factor, in the development of DCs with distinct properties. This review summarizes the role of different cytokine cocktails in the in vitro generation of human DCs from blood monocyte precursors, focusing on GM-CSF as a direct player in the generation of functionally distinct DCs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18926300     DOI: 10.1016/j.imbio.2008.07.017

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  36 in total

Review 1.  Intratumoral Immunotherapy-Update 2019.

Authors:  Omid Hamid; Rubina Ismail; Igor Puzanov
Journal:  Oncologist       Date:  2019-11-29

Review 2.  Generation of immunogenic and tolerogenic clinical-grade dendritic cells.

Authors:  Tahereh Kalantari; Eskandar Kamali-Sarvestani; Bogoljub Ciric; Mohamad H Karimi; Mohsen Kalantari; Alireza Faridar; Hui Xu; Abdolmohamad Rostami
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

3.  A suppressor of cytokine signaling 1 antagonist enhances antigen-presenting capacity and tumor cell antigen-specific cytotoxic T lymphocyte responses by human monocyte-derived dendritic cells.

Authors:  Yongjun Wang; Shengyu Wang; Yuan Ding; Yanhua Ye; Yingyi Xu; Huixiang He; Qiaozhen Li; Yanjun Mi; Chunhua Guo; Zhicai Lin; Tao Liu; Yaya Zhang; Yuqiang Chen; Jianghua Yan
Journal:  Clin Vaccine Immunol       Date:  2013-07-24

4.  Alternative modes of GM-CSF receptor activation revealed using activated mutants of the common beta-subunit.

Authors:  Michelle Perugini; Anna L Brown; Diana G Salerno; Grant W Booker; Cvetan Stojkoski; Timothy R Hercus; Angel F Lopez; Margaret L Hibbs; Thomas J Gonda; Richard J D'Andrea
Journal:  Blood       Date:  2010-02-19       Impact factor: 22.113

Review 5.  GM-CSF: An immune modulatory cytokine that can suppress autoimmunity.

Authors:  Palash Bhattacharya; Muthusamy Thiruppathi; Hatem A Elshabrawy; Khaled Alharshawi; Prabhakaran Kumar; Bellur S Prabhakar
Journal:  Cytokine       Date:  2015-06-22       Impact factor: 3.861

6.  A GMCSF-neuroantigen fusion protein is a potent tolerogen in experimental autoimmune encephalomyelitis (EAE) that is associated with efficient targeting of neuroantigen to APC.

Authors:  J Lori Blanchfield; Mark D Mannie
Journal:  J Leukoc Biol       Date:  2010-03       Impact factor: 4.962

7.  IL-33 promotes DC development in BM culture by triggering GM-CSF production.

Authors:  Nobuyasu Mayuzumi; Hironori Matsushima; Akira Takashima
Journal:  Eur J Immunol       Date:  2009-12       Impact factor: 5.532

8.  Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma.

Authors:  Igor Puzanov; Mohammed M Milhem; David Minor; Omid Hamid; Ai Li; Lisa Chen; Michael Chastain; Kevin S Gorski; Abraham Anderson; Jeffrey Chou; Howard L Kaufman; Robert H I Andtbacka
Journal:  J Clin Oncol       Date:  2016-06-13       Impact factor: 44.544

Review 9.  Granulocyte-macrophage colony-stimulating factor: not just another haematopoietic growth factor.

Authors:  Alejandro Francisco-Cruz; Miguel Aguilar-Santelises; Octavio Ramos-Espinosa; Dulce Mata-Espinosa; Brenda Marquina-Castillo; Jorge Barrios-Payan; Rogelio Hernandez-Pando
Journal:  Med Oncol       Date:  2013-11-22       Impact factor: 3.064

10.  Biologics in dermatologic therapy - an update.

Authors:  Arijit Coondoo
Journal:  Indian J Dermatol       Date:  2009-07       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.